Xénia Faktorová, M. Žigrai, Silvia Žigraiová, L. Horniaková, Svetlana Adamcová Selčanová, Roman Belica, D. Guga, M. Vyskočil
{"title":"“胆管消失综合征”作为多处外伤患者药物性肝损害的表现","authors":"Xénia Faktorová, M. Žigrai, Silvia Žigraiová, L. Horniaková, Svetlana Adamcová Selčanová, Roman Belica, D. Guga, M. Vyskočil","doi":"10.48095/ccgh2022499","DOIUrl":null,"url":null,"abstract":"Summary: Vanishing bile duct syndrome is a type of drug-induced cholestatic liver injury that occurs when the body is exposed to drugs or other foreign substances. We hospitalized a 44-year-old, so far healthy, male with gradually developing painless icterus and pruritus of the whole body after severe polytrauma. The patient had previously undergone a complex treatment (antibio tics, antifungals, parenteral nutrition, LMWH). Laboratory tests revealed a several-fold elevation of total and conjugated bilirubin with a 3-fold increase in ALP levels, no signifi cant elevation of transaminases, a decrease in prothrombin time and IgG4 antibody positivity. An MRCP scan was performed revealing irregular intrahepatic bile ducts, a dilated common bile duct and characteristics of primary or secondary sclerosing cholangitis. Further examinations ruled out infectious, metabolic, toxic and oncological causes of hepatopathy. A liver bio psy ruled out both autoimmune hepatitis and IgG4 hepatopathy and displayed images of “vanishing bile duct syndrome” in drug-induced liver injury (DILI). Empirical treatment with high-dose intravenous N-acetylcysteine and other hepatoprotective agents led to a gradual decrease of bilirubin, normalization of coagulation parameters and remission of icterus and clinical complaints. This case report points to a cholestatic type of drug-induced liver injury with histologically confi rmed vanishing bile duct syndrome and the need to think of DILI as one of the causes of the otherwise unexplained hepatopathy. Key words: cholangitis – DILI – hepatopathy – IgG4 – vanishing bile duct syndrome","PeriodicalId":38577,"journal":{"name":"Gastroenterologie a Hepatologie","volume":"57 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"“Vanishing bile duct syndrome” as a manifestation of drug-induced liver damage in a patient after polytrauma\",\"authors\":\"Xénia Faktorová, M. Žigrai, Silvia Žigraiová, L. Horniaková, Svetlana Adamcová Selčanová, Roman Belica, D. Guga, M. Vyskočil\",\"doi\":\"10.48095/ccgh2022499\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Summary: Vanishing bile duct syndrome is a type of drug-induced cholestatic liver injury that occurs when the body is exposed to drugs or other foreign substances. We hospitalized a 44-year-old, so far healthy, male with gradually developing painless icterus and pruritus of the whole body after severe polytrauma. The patient had previously undergone a complex treatment (antibio tics, antifungals, parenteral nutrition, LMWH). Laboratory tests revealed a several-fold elevation of total and conjugated bilirubin with a 3-fold increase in ALP levels, no signifi cant elevation of transaminases, a decrease in prothrombin time and IgG4 antibody positivity. An MRCP scan was performed revealing irregular intrahepatic bile ducts, a dilated common bile duct and characteristics of primary or secondary sclerosing cholangitis. Further examinations ruled out infectious, metabolic, toxic and oncological causes of hepatopathy. A liver bio psy ruled out both autoimmune hepatitis and IgG4 hepatopathy and displayed images of “vanishing bile duct syndrome” in drug-induced liver injury (DILI). Empirical treatment with high-dose intravenous N-acetylcysteine and other hepatoprotective agents led to a gradual decrease of bilirubin, normalization of coagulation parameters and remission of icterus and clinical complaints. This case report points to a cholestatic type of drug-induced liver injury with histologically confi rmed vanishing bile duct syndrome and the need to think of DILI as one of the causes of the otherwise unexplained hepatopathy. Key words: cholangitis – DILI – hepatopathy – IgG4 – vanishing bile duct syndrome\",\"PeriodicalId\":38577,\"journal\":{\"name\":\"Gastroenterologie a Hepatologie\",\"volume\":\"57 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gastroenterologie a Hepatologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.48095/ccgh2022499\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastroenterologie a Hepatologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48095/ccgh2022499","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
摘要
摘要:胆管消失综合征是一种药物性胆汁淤积性肝损伤,当机体暴露于药物或其他异物时发生。我们收治了一名44岁,至今健康的男性,在严重多发创伤后逐渐发展为无痛性黄疸和全身瘙痒。该患者此前接受过复杂的治疗(抗生素、抗真菌药物、肠外营养、低分子肝素)。实验室检查显示总胆红素和结合胆红素升高数倍,ALP水平升高3倍,转氨酶无明显升高,凝血酶原时间减少,IgG4抗体阳性。MRCP扫描显示肝内胆管不规则,胆总管扩张和原发性或继发性硬化性胆管炎的特征。进一步的检查排除了感染性、代谢性、毒性和肿瘤性肝病。肝脏活检排除自身免疫性肝炎和IgG4肝病,并显示药物性肝损伤(DILI)的“胆管消失综合征”图像。经验性大剂量静脉注射n -乙酰半胱氨酸等护肝药物治疗后,胆红素逐渐下降,凝血指标恢复正常,黄疸及临床症状得到缓解。本病例报告指出了一种胆汁淤积型药物性肝损伤,组织学证实为胆管消失综合征,需要考虑DILI是其他原因不明的肝病的原因之一。关键词:胆管炎- DILI -肝病- IgG4 -胆管消失综合征
“Vanishing bile duct syndrome” as a manifestation of drug-induced liver damage in a patient after polytrauma
Summary: Vanishing bile duct syndrome is a type of drug-induced cholestatic liver injury that occurs when the body is exposed to drugs or other foreign substances. We hospitalized a 44-year-old, so far healthy, male with gradually developing painless icterus and pruritus of the whole body after severe polytrauma. The patient had previously undergone a complex treatment (antibio tics, antifungals, parenteral nutrition, LMWH). Laboratory tests revealed a several-fold elevation of total and conjugated bilirubin with a 3-fold increase in ALP levels, no signifi cant elevation of transaminases, a decrease in prothrombin time and IgG4 antibody positivity. An MRCP scan was performed revealing irregular intrahepatic bile ducts, a dilated common bile duct and characteristics of primary or secondary sclerosing cholangitis. Further examinations ruled out infectious, metabolic, toxic and oncological causes of hepatopathy. A liver bio psy ruled out both autoimmune hepatitis and IgG4 hepatopathy and displayed images of “vanishing bile duct syndrome” in drug-induced liver injury (DILI). Empirical treatment with high-dose intravenous N-acetylcysteine and other hepatoprotective agents led to a gradual decrease of bilirubin, normalization of coagulation parameters and remission of icterus and clinical complaints. This case report points to a cholestatic type of drug-induced liver injury with histologically confi rmed vanishing bile duct syndrome and the need to think of DILI as one of the causes of the otherwise unexplained hepatopathy. Key words: cholangitis – DILI – hepatopathy – IgG4 – vanishing bile duct syndrome